Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective

Annalisa Del Prete, Beatriz Duran Jimenez, Anne Black

Open source

DOI
10.1177/10430342261473434
Published
2026-08-12
Container
Human Gene Therapy
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10430342261473434,
  title = {Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective},
  author = {Annalisa Del Prete and Beatriz Duran Jimenez and Anne Black},
  year = {2026},
  journal = {Human Gene Therapy},
  doi = {10.1177/10430342261473434},
  url = {https://doi.org/10.1177/10430342261473434}
}

RIS

TY  - JOUR
TI  - Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective
AU  - Annalisa Del Prete
AU  - Beatriz Duran Jimenez
AU  - Anne Black
PY  - 2026
JO  - Human Gene Therapy
DO  - 10.1177/10430342261473434
UR  - https://doi.org/10.1177/10430342261473434
ER  - 

APA

Prete, A. D., Jimenez, B. D., & Black, A. (2026). Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective. Human Gene Therapy. https://doi.org/10.1177/10430342261473434

Source records